ZIM
ZBH icon

Zacks Investment Management’s Zimmer Biomet ZBH Stock Holding History

Zacks Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-70,300
Closed -$8.56M – 720
2023
Q4 		$8.56M Sell
70,300
-501
-0.7% -$55.9K 0.11% 155
2023
Q3 		$7.95M Buy
70,801
+2,332
+3% +$296K 0.1% 158
2023
Q2 		$9.97M Buy
+68,469
New +$9.3M 0.13% 141
2016
Q4 		– Sell
-35,685
Closed -$4.5M – 749
2016
Q3 		$4.5M Buy
+35,685
New +$4.41M 0.13% 141

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Zacks Investment Management's ZBH Position: Q1 2024 in Review

Zacks Investment Management sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 70,300 shares — an estimated $8.56M sold.

Zacks Investment Management first reported a position in ZBH in Q3 2016 and held it in 4 quarters. The position peaked at $9.97M in Q2 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Zacks Investment Management reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Zacks Investment Management sold 70,300 Zimmer Biomet shares in Q1 2024, an estimated $8.56M.
  • Zacks Investment Management first reported a position in Zimmer Biomet in Q3 2016 and held it in 4 quarters.
  • Zacks Investment Management's Zimmer Biomet position peaked at $9.97M in Q2 2023.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Zacks Investment Management's 13F filing for Q1 2024, filed 15 May 2024.